Fine-tuning ALK1 linear polyubiquitination to control angiogenesis.
ALK1
BMP9
LUBAC
OTULIN
angiogenesis
arteriovenous malformation
Journal
Trends in cell biology
ISSN: 1879-3088
Titre abrégé: Trends Cell Biol
Pays: England
ID NLM: 9200566
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
19
07
2021
revised:
19
07
2021
accepted:
19
07
2021
pubmed:
1
8
2021
medline:
15
12
2021
entrez:
31
7
2021
Statut:
ppublish
Résumé
Editing linear polyubiquitination of protein substrates by LUBAC and OTULIN is known to play a critical role in immune responses. A recent study by Fu et al. reveals how reversible linear polyubiquitination of the activin receptor-like kinase (ALK1) controls developmental angiogenesis and how its dysfunction leads to vascular malformations in humans.
Identifiants
pubmed: 34330579
pii: S0962-8924(21)00144-6
doi: 10.1016/j.tcb.2021.07.004
pii:
doi:
Substances chimiques
Activin Receptors, Type II
EC 2.7.11.30
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
705-707Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.